Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>WUXI BIO Annual NP RMB4.908B, Up 46.3%; Adj. NP Up 17.9%
Recommend 9 Positive 16 Negative 1 |
||||
|
||||
|
WUXI BIO (02269.HK) announced its full-year results for the year ended December 31, 2025. Revenue reached RMB21.79 billion, a YoY rise of 16.7%. It recorded net profit of RMB4.908 billion, a YoY hike of 46.3%, with an EPS of RMB1.22. Gross profit added by 30.9% YoY to RMB10.019 billion, and the gross profit margin improved by 5% YoY to 46%. Excluding share-based compensation expense, foreign exchange gains or losses, gains or losses from equity investments, assets divestiture and retirement, and related one-time costs, the Group's adjusted net profit grew 17.9% to RMB5.64 billion, and the adjusted net profit margin lifted by 0.3 ppts to 25.9%. No dividend was declared. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
